Surfactin exhibits neuroprotective effects by inhibiting amyloid β-mediated microglial activation

NeuroToxicology

Volumn 38, Issue , 2013, Pages 115-123

  Park, Sun Young ^a   Kim, Ji Hee ^a   Lee, Sang Joon ^a   Kim, YoungHee ^a  

^a Pusan National University   (South Korea)

Author keywords

Amyloid ; Inflammation; Microglia; Neurotoxicity; Surfactin

Indexed keywords

AMYLOID BETA PROTEIN; CYCLOOXYGENASE 2; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; OLIGOMER; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; SURFACTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; IN VITRO STUDY; MICROGLIA; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

AMYLOID Β; INFLAMMATION; MICROGLIA; NEUROTOXICITY; SURFACTIN;

AMYLOID BETA-PEPTIDES; ANIMALS; CELLS, CULTURED; CHEMOKINE CCL2; CYCLOOXYGENASE 2; DINOPROSTONE; HIPPOCAMPUS; INTERLEUKIN-1BETA; INTERLEUKIN-6; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPEPTIDES; MATRIX METALLOPROTEINASE 9; MICE; MICROGLIA; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDES, CYCLIC; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84882797854     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2013.07.004     Document Type: Article

References (48)

1. Agostinho P., Cunha R.A., Oliveira C. Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease. Curr Pharm Des 2010, 16:2766-2778.
2. Agrawal S.M., Lau L., Yong V.W. MMPs in the central nervous system: where the good guys go bad. Semin Cell Dev Biol 2008, 19:42-51.
3. Bachstetter A.D., Xing B., de Almeida L., Dimayuga E.R., Watterson D.M., Van Eldik L.J. Microglial p38alpha MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Abeta). J Neuroinflammation 2011, 8:79.
4. Bal-Price A., Brown G.C. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci 2001, 21:6480-6491.
5. Banati R.B., Gehrmann J., Schubert P., Kreutzberg G.W. Cytotoxicity of microglia. Glia 1993, 7:111-118.
6. Boje K.M., Arora P.K. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 1992, 587:250-256.
7. Brown J., Wang H., Hajishengallis G.N., Martin M. TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. J Dent Res 2011, 90:417-427.
8. Byeon S.E., Lee Y.G., Kim B.H., Shen T., Lee S.Y., Park H.J., et al. Surfactin blocks NO production in lipopolysaccharide-activated macrophages by inhibiting NF-kappaB activation. J Microbiol Biotechnol 2008, 18:1984-1989.
9. Candelario-Jalil E., Yang Y., Rosenberg G.A. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 2009, 158:983-994.
10. Cao X., Wang A.H., Jiao R.Z., Wang C.L., Mao D.Z., Yan L., et al. Surfactin induces apoptosis and G(2)/M arrest in human breast cancer MCF-7 cells through cell cycle factor regulation. Cell Biochem Biophys 2009, 55:163-171.
11. Cao X.H., Wang A.H., Wang C.L., Mao D.Z., Lu M.F., Cui Y.Q., et al. Surfactin induces apoptosis in human breast cancer MCF-7 cells through a ROS/JNK-mediated mitochondrial/caspase pathway. Chem Biol Interact 2010, 183:357-362.
12. Chao C.C., Hu S., Molitor T.W., Shaskan E.G., Peterson P.K. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 1992, 149:2736-2741.
13. Chinta S.J., Ganesan A., Reis-Rodrigues P., Lithgow G.J., Andersen J.K. Anti-inflammatory role of the isoflavone diadzein in lipopolysaccharide-stimulated microglia: implications for Parkinson's disease. Neurotox Res 2012.
14. Coomaraswamy J., Kilger E., Wolfing H., Schafer C., Kaeser S.A., Wegenast-Braun B.M., et al. Modeling familial Danish dementia in mice supports the concept of the amyloid hypothesis of Alzheimer's disease. Proc Natl Acad Sci U S A 2010, 107:7969-7974.
15. Cui Y., Wu J., Jung S.C., Kim G.O., Kyeong Ko R., Lee H.J., et al. Neuroprotective effect of methyl lucidone against microglia-mediated neurotoxicity. Eur J Pharmacol 2012, 690:4-12.
16. Dean J.M., Wang X., Kaindl A.M., Gressens P., Fleiss B., Hagberg H., et al. Microglial MyD88 signaling regulates acute neuronal toxicity of LPS-stimulated microglia in vitro. Brain Behav Immun 2010, 24:776-783.
17. del Zoppo G.J., Milner R., Mabuchi T., Hung S., Wang X., Berg G.I., et al. Microglial activation and matrix protease generation during focal cerebral ischemia. Stroke 2007, 38:646-651.
18. del Zoppo G.J., Frankowski H., Gu Y.H., Osada T., Kanazawa M., Milner R., et al. Microglial cell activation is a source of metalloproteinase generation during hemorrhagic transformation. J Cereb Blood Flow Metab 2012, 32:919-932.
19. Doherty G.H. Nitric oxide in neurodegeneration: potential benefits of non-steroidal anti-inflammatories. Neurosci Bull 2011, 27:366-382.
20. Elmann A., Mordechay S., Erlank H., Telerman A., Rindner M., Ofir R. Anti-neuroinflammatory effects of the extract of Achillea fragrantissima. BMC Complement Altern Med 2011, 11:98.
21. Ferretti M.T., Cuello A.C. Does a pro-inflammatory process precede Alzheimer's disease and mild cognitive impairment. Curr Alzheimer Res 2011, 8:164-174.
22. Gottschall P.E. Beta-amyloid induction of gelatinase B secretion in cultured microglia: inhibition by dexamethasone and indomethacin. Neuroreport 1996, 7:3077-3080.
23. Harry G.J., Kraft A.D. Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment. Expert Opin Drug Metab Toxicol 2008, 4:1265-1277.
24. Kalaria R.N., Cohen D.L., Premkumar D.R. Cellular aspects of the inflammatory response in Alzheimer's disease. Neurodegeneration 1996, 5:497-503.
25. Kataria H., Wadhwa R., Kaul S.C., Kaur G. Water extract from the leaves of Withania somnifera protect RA differentiated C6 and IMR-32 cells against glutamate-induced excitotoxicity. PLoS ONE 2012, 7:e37080.
26. Kim S.Y., Kim J.Y., Kim S.H., Bae H.J., Yi H., Yoon S.H., et al. Surfactin from Bacillus subtilis displays anti-proliferative effect via apoptosis induction, cell cycle arrest and survival signaling suppression. FEBS Lett 2007, 581:865-871.
27. Kim Y.J., Hwang S.Y., Oh E.S., Oh S., Han I.O. IL-1beta an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-kappaB pathways. J Neurosci Res 2006, 84:1037-1046.
28. Liu X., Ren B., Gao H., Liu M., Dai H., Song F., et al. Optimization for the production of surfactin with a new synergistic antifungal activity. PLoS ONE 2012, 7:e34430.
29. Lorenzl S., Albers D.S., Relkin N., Ngyuen T., Hilgenberg S.L., Chirichigno J., et al. Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease. Neurochem Int 2003, 43:191-196.
30. Magrone T., Marzulli G., Jirillo E. Immunopathogenesis of neurodegenerative diseases: current therapeutic models of neuroprotection with special reference to natural products. Curr Pharm Des 2012, 18:34-42.
31. Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 2004, 63:901-910.
32. Offen D., Gilgun-Sherki Y., Barhum Y., Benhar M., Grinberg L., Reich R., et al. A low molecular weight copper chelator crosses the blood-brain barrier and attenuates experimental autoimmune encephalomyelitis. J Neurochem 2004, 89:1241-1251.
33. Park J.S., Park E.M., Kim D.H., Jung K., Jung J.S., Lee E.J., et al. Anti-inflammatory mechanism of ginseng saponins in activated microglia. J Neuroimmunol 2009, 209:40-49.
34. Park S.Y., Kim Y. Surfactin inhibits immunostimulatory function of macrophages through blocking NK-kappaB, MAPK and Akt pathway. Int Immunopharmacol 2009, 9:886-893.
35. Park S.Y., Kim Y.H., Kim E.K., Ryu E.Y., Lee S.J. Heme oxygenase-1 signals are involved in preferential inhibition of pro-inflammatory cytokine release by surfactin in cells activated with Porphyromonas gingivalis lipopolysaccharide. Chem Biol Interact 2010, 188:437-445.
36. Pereira C., Agostinho P., Moreira P.I., Cardoso S.M., Oliveira C.R. Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies. Curr Drug Targets CNS Neurol Disord 2005, 4:383-403.
37. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 1993, 13:1676-1687.
38. Qi G., Zhu F., Du P., Yang X., Qiu D., Yu Z., et al. Lipopeptide induces apoptosis in fungal cells by a mitochondria-dependent pathway. Peptides 2010, 31:1978-1986.
39. Rubio-Perez J.M., Morillas-Ruiz J.M. A review: inflammatory process in Alzheimer's disease, role of cytokines. Sci. World J. 2012, 2012:756357.
40. Sanchez-Pernaute R., Ferree A., Cooper O., Yu M., Brownell A.L., Isacson O. Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease. J Neuroinflammation 2004, 1:6.
41. Son G.H., Kim J., Muthaiya M.J., Lee S., Kim H.Y., Lee C.H. Antimicrobial compounds profile during Cheonggukjang fermentation against Xanthomonas oryzae pv. oryzae (Xoo). J Microbiol Biotechnol 2011, 21:1147-1150.
42. Streit W.J., Conde J.R., Fendrick S.E., Flanary B.E., Mariani C.L. Role of microglia in the central nervous system's immune response. Neurol Res 2005, 27:685-691.
43. Svedin P., Hagberg H., Savman K., Zhu C., Mallard C. Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. J Neurosci 2007, 27:1511-1518.
44. Tieu K., Ischiropoulos H., Przedborski S. Nitric oxide and reactive oxygen species in Parkinson's disease. IUBMB Life 2003, 55:329-335.
45. Van Eldik L.J., Thompson W.L., Ralay Ranaivo H., Behanna H.A., Martin Watterson D. Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches. Int Rev Neurobiol 2007, 82:277-296.
46. Vitner E.B., Farfel-Becker T., Eilam R., Biton I., Futerman A.H. Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease. Brain 2012, 135:1724-1735.
47. Wei T., Chen C., Hou J., Xin W., Mori A. Nitric oxide induces oxidative stress and apoptosis in neuronal cells. Biochim Biophys Acta 2000, 1498:72-79.
48. Yang G., Meng Y., Li W., Yong Y., Fan Z., Ding H., et al. Neuronal MCP-1 mediates microglia recruitment and neurodegeneration induced by the mild impairment of oxidative metabolism. Brain Pathol 2011, 21:279-297.